LotusDx Opens R&D Lab to Develop At-Home STI Tests
The facility will support the clinical validation of diagnostic kits that provide results via a mobile app without the need for laboratory processing.
The facility will support the clinical validation of diagnostic kits that provide results via a mobile app without the need for laboratory processing.
A Boston University study found TB DNA in 12% to 16% of respiratory samples from hospitalized patients in a low-incidence area using an ultrasensitive assay, suggesting underdiagnosis of tuberculosis in the US.
Research identifies how circulating tumor DNA can inform personalized treatment and surveillance strategies.
A field-deployable test demonstrates high sensitivity in identifying low-level infections that traditional methods miss, potentially supporting elimination efforts.
Visby Medical and Watchmaker Genomics have partnered to develop at-home PCR respiratory tests designed to overcome molecular inhibitors found in unprocessed clinical samples, according to a joint announcement.
The PCR test detects 11 bacterial, viral, and parasitic pathogens from a stool sample in approximately 74 minutes.
The HIV self-test has received Health Canada approval, making it the first oral HIV self-test available in Canada. Results are provided in 20 minutes with an oral swab.